1.
|
4 p, 111.4 KB |
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria
/
Griffin, Morag (Department of Hematology. St James University Hospitals) ;
Eikema, Dirk-Jan (EBMT Statistical Unit) ;
Verheggen, Inge (EBMT Leiden Study Unit) ;
Kulagin, Alexander (Pavlov University) ;
Tjon, Jennifer M-L (Department of Hematology. Leiden University Medical Center) ;
Fattizzo, Bruno (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Ingram, Wendy (Department of Hematology. University Hospital of Wales) ;
Zaidi, Uzma (National Institute of Blood Disease & Bone Marrow Transplantation) ;
Desnica, Lana (Department of Hematology. University Hospital Center Zagreb) ;
Giammarco, Sabrina (Dipartimento di Diagnostica per Immagini. Radioterapia Oncologica ed Ematologia. Fondazione Policlinico Universitario A. Gemelli IRCCS) ;
Drozd-Sokolowska, Joanna (Department of Hematology. Medical University of Warsaw) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Patriarca, Andrea (AOU Maggiore della Carità (Itàlia)) ;
Loschi, Michael (Cote d'Azur University) ;
Szmigielska-Kaplon, Anna (Department of Hematology. Copernicus Hospital) ;
Beier, F. (RWTH Aachen University) ;
Cignetti, Alessandro (University Division of Hematology) ;
Drexler, Beatrice (University Hospital Basel (Basilea, Suïssa)) ;
Gavriilaki, Eleni (Department of Hematology. George Papanicolaou General Hospital) ;
Lanza, Francesco (Hospital Santa Maria delle Croci) ;
Orvain, Corentin (Centre Hospitalier Universitaire d'Angers) ;
Risitano, Antonio Maria (Department of Hematology. AORN Moscati) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Peffault de Latour, Régis (Hôpital Saint-Louis)
2024 - 10.3324/haematol.2023.283863
Haematologica, Vol. 109 Núm. 1 (january 2024) , p. 283-286
|
|
2.
|
8 p, 930.0 KB |
Ruxolitinib in refractory acute and chronic graft-versus-host disease : a multicenter survey study
/
Escamilla Gómez, V. (Universidad de Sevilla) ;
García-Gutiérrez, Valentín (University Hospital Ramon y Cajal) ;
López Corral, Lucía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Pérez Martínez, Ariadna (Hospital Clínic Universitari (València)) ;
Márquez Malaver, F.J. (Universidad de Sevilla) ;
Caballero Velazquez, Teresa (Universidad de Sevilla) ;
González Sierra, P.A. (Hospital Universitario (Granada)) ;
Viguria Alegría, M.C. (Complejo Hospitalario de Navarra) ;
Parra Salinas, I.M. (Hospital Universitario Miguel Servet (Saragossa)) ;
Calderón Cabrera, C. (Universidad de Sevilla) ;
González Vicent, M. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Rodríguez Torres, N. (Universidad de Sevilla) ;
Parody Porras, R. (Instituto Catalá de Oncología Hospitalet) ;
Ferrá, Christelle (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Orti, Guillermo (Hospital Universitari Vall d'Hebron) ;
Valcárcel Ferreiras, D. (Hospital Universitari Vall d'Hebron) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Molés, P. (Hospital Universitari i Politècnic La Fe (València)) ;
Velázquez-Kennedy, K. (Hospital Universitari Ramon y Cajal) ;
João Mende, M. (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Caballero, Dolores (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Pérez, Estefanía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Saavedra Gerosa, Silvana Daniela (Institut d'Investigació Biomèdica Sant Pau) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Poch, M. (Clinic Hospital Universitari de Valencia) ;
Zudaire Ripa, M.T. (Complejo Hospitalario de Navarra) ;
Díaz Pérez, M.A. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Molina Angulo, B. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Sánchez Ortega, I. (Instituto Catalá de Oncología Hospitalet) ;
Sanz Caballer, J. (Hospital Universitari i Politècnic La Fe (València)) ;
Montoro Gómez, J. (Hospital Universitari i Politècnic La Fe (València)) ;
Espigado Tocino, I. (Universidad de Sevilla) ;
Pérez-Simón, J.A. (Universidad de Sevilla) ;
Universitat Autònoma de Barcelona
Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. [...]
2020 - 10.1038/s41409-019-0731-x
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 641-648
|
|
3.
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
4.
|
9 p, 1.0 MB |
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
/
Cruz, David (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Rodríguez-Romanos, Rocío (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
González-Bartulos, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Heras, Inmaculada (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Buño, Ismael (Hospital General Universitario Gregorio Marañón) ;
Santos, Nazly (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Lloveras, Natàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Velarde, Pilar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Tuset, Esperanza (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Martínez, Carmen (Hospital Clínic i Provincial de Barcelona) ;
González, Marcos (Hospital Clínico Universitario (Salamanca)) ;
Sanz, Guillermo F. (Hospital Universitari i Politècnic La Fe (València)) ;
Ferrá, Christelle (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Sampol, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Coll, Rosa (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Pérez-Simón, Jose A. (Universidad de Sevilla) ;
López-Jiménez, Javier (Hospital Universitario Ramón y Cajal (Madrid)) ;
Jurado, Manuel (Hospital Universitario Virgen de las Nieves (Granada)) ;
Gallardo, David (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Universitat Autònoma de Barcelona
The association of polymorphisms in molecules involved in the immune response (checkpoint inhibitors) with the clinical outcome after allogeneic transplantation (alloHSCT) has been described. Lymphocyte Activation 3 (LAG3) is a surface protein that plays a regulatory role in immunity as an inhibitory immune checkpoint molecule. [...]
2023 - 10.3389/fimmu.2023.1066393
Frontiers in immunology, Vol. 14 (january 2023)
|
|
5.
|
10 p, 1.1 MB |
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
/
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Mikulska, Malgorzata (Division of Infectious Diseases. University of Genoa and Ospedale Policlinico San Martino) ;
Tridello, G. (Pediatric Hematology Oncology) ;
Aguado, Beatriz (Instituto de Investigación Hospital Universitario de la Princesa) ;
Zahrani, M.A. (King Abdul - Aziz Medical City) ;
Apperley, Jane (Centre for Haematology. Imperial College) ;
Berceanu, A. (Hopital Jean Minjoz) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
Ciceri, Fabio (Ospedale San Raffaele s.r.l.) ;
Lopez-Corral, L. (Hematology Department. Complejo Asistencial Universitario de Salamanca-IBSAL; Centro de Investigación del Cáncer-IBMCC) ;
Crippa, C. (Spedali Civili) ;
Fox, M.L. (Vall d'Hebron Institut d'Oncologia) ;
Grassi, A. (ASST Papa Giovanni XXIII) ;
Jimenez, M.J. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Demir, S.K. (HSCT unit. Demiroglu Bilim University) ;
Kwon, Mi (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Llamas, C.V. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Lorenzo, J.L.L. (Hospital Universitario Fundación Jiménez Díaz) ;
Mielke, S. (Karolinska Institutet (Estocolm, Suècia). Department of Laboratory Medicine) ;
Orchard, K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Porras, R.P. (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Vallisa, D. (Hospital Guglielmo da Saliceto) ;
Xhaard, A. (Hôpital St. Louis) ;
Knelange, N.S. (EBMT Data Office. Department of Medical Statistics & Bioinformatics) ;
Cedillo, Angel (GETH Spanish Registry) ;
Kroeger, Nicolaus (Department of Stem cell Transplantation. University Hospital Eppendorf) ;
Piñana, José Luis (Hospital Clínic Universitari (València)) ;
Styczynski, Jan (Pediatric Hematology and Oncology. University Hospital. Collegium Medicum. Nicolaus Copernicus University Torun)
This study reports on 382 COVID-19 patients having undergone allogeneic (n = 236) or autologous (n = 146) hematopoietic cell transplantation (HCT) reported to the European Society for Blood and Marrow Transplantation (EBMT) or to the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH). [...]
2021 - 10.1038/s41375-021-01302-5
Leukemia, Vol. 35 Núm. 10 (october 2021) , p. 2885-2894
|
|